An orally-available monovalent SMAC mimetic compound as a broad-spectrum antiviral
Accepted date: 15 May 2023
Copyright
Miao Mei , Maria_Antonietta Impagnatiello , Jun Jiao , Ulrich Reiser , Ulrike Tontsch-Grunt , Ju Zhang , Paul Nicklin , Bingke Yu , Yu Wang , Yuan He , Xu Tan . An orally-available monovalent SMAC mimetic compound as a broad-spectrum antiviral[J]. Protein & Cell, 2024 , 15(1) : 69 -75 . DOI: 10.1093/procel/pwad033
| 1 |
Bai L, Smith DC, Wang S. Small-molecule SMAC mimetics as new cancer therapeutics. Pharmacol Ther 2014;144:82–95.
|
| 2 |
Chitalia VC, Munawar AH. A painful lesson from the COVID-19 pandemic: the need for broad-spectrum, host-directed antivirals. J Transl Med 2020;18:390.
|
| 3 |
Clark MP, Huynh T, Rao S et al. Clinical stage drugs targeting inhibitor of apoptosis proteins purge episomal Hepatitis B viral genome in preclinical models. Cell Death Dis 2021;12:641.
|
| 4 |
Ebert G, Allison C, Preston S et al. Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis. Proc Natl Acad Sci USA 2015;112:5803–5808.
|
| 5 |
Ladner SK, Otto MJ, Barker CS et al. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob Agents Chemother 1997;41:1715–1720.
|
| 6 |
Li G, Zhu Y, Shao D et al. Recombinant covalently closed circular DNA of hepatitis B virus induces long-term viral persistence with chronic hepatitis in a mouse model. Hepatology 2018;67:56–70.
|
| 7 |
Maini MK, Boni C, Lee CK et al. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 2000;191:1269–1280.
|
| 8 |
Mei M, Tan X. Current strategies of antiviral drug discovery for COVID-19. Front Mol Biosci 2021;8:671263.
|
| 9 |
Molyer B, Kumar A, Angel JB. SMAC mimetics as therapeutic agents in HIV infection. Front Immunol 2021;12:780400.
|
| 10 |
Pache L, Dutra MS, Spivak AM et al. BIRC2/cIAP1 is a negative regulator of HIV-1 transcription and can be targeted by Smac mimetics to promote reversal of viral latency. Cell Host Microbe 2015;18:345–353.
|
| 11 |
Pache L, Marsden MD, Teriete P et al. Pharmacological activation of non-canonical NF-kappaB signaling activates latent HIV-1 reservoirs in vivo. Cell Rep Med 2020;1:100037.
|
| 12 |
Petersen SL, Wang L, Yalcin-Chin A et al. Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis. Cancer Cell 2007;12:445–456.
|
| 13 |
Xiang C, Du Y, Meng G et al. Long-term functional maintenance of primary human hepatocytes in vitro. Science 2019;364:399–402.
|
| 14 |
Yang PL, Althage A, Chung J et al. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc Natl Acad Sci USA 2002;99: 13825–13830.
|
/
| 〈 |
|
〉 |